Small Molecule Prefilled Syringes Market Analysis | CMI - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Small Molecule Prefilled Syringes Market Analysis | CMI

Description:

Read here the latest updates on the Small Molecule Prefilled Syringes Market published by CMI team – PowerPoint PPT presentation

Number of Views:1

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Small Molecule Prefilled Syringes Market Analysis | CMI


1
  • Coherent Market Insights
  • Market Research and Business Consulting Services
  • https//www.coherentmarketinsights.com/
  • COVID-19 Impact Tracker

2
SMALL MOLECULE PREFILLED SYRINGES MARKET ANALYSIS
  • Small Molecule Prefilled Syringes Market, by Drug
    Class (Cardiovascular Drugs, Neurology Drugs,
    Analgesics, Adjuvants, and Others), By Material
    (Glass, and Plastic Polymer) and Region -
    Global Trends and Forecast to 2025
  • The global small molecule prefilled syringes
    market was valued at US 13,749.4 million in 2016
    and is expected to witness a robust CAGR of 4.6
    over the forecast period (20172025).

3
Market Drivers
  • Development of technologically advanced prefilled
    syringes is expected to boost demand for Small
    Molecule Prefilled Syringes
  • Manufacturers are engaged in development of dual
    or multi-chambered prefilled syringes (AL
    Biosciences, Inc. manufacturers multi-chambered
    prefilled syringe), which have various
    applications in areas such as reconstituted drugs
    and other potent drugs (for instant therapeutic
    action). These also offer convenience to end
    users. Furthermore, technological advancements in
    design and manufacturing of prefilled syringes
    have also aided pharmaceutical players to
    commercialize various drugs into prefilled dosage
    forms such as Penicillin. Several pharmaceutical
    players have developed prefilled syringes
    containing active pharmaceutical ingredients,
    which has aided these players in increasing their
    revenues. For instance, Teva Pharmaceutical
    Industries Ltd. earned significant revenues from
    the sale of its drug Copaxone in 2016, which
    comes in a prefilled syringe. Manufacturers of
    prefilled syringe have developed innovative
    prefilled syringes and dual- and multi-chambered
    syringes for sensitive drugs to avoid reactions.
    The drug chamber is separated with diluent
    chamber with a barrel in between the two chambers
    and the barrel serves as a barrier between two
    chambers. For instance, Pfizer, Inc. has iSecure
    one piece prefilled syringe without needle.
    iSecure is a one- piece, needle-free technology
    which helps in minimizing needle-stick injuries.

4
Figure 1. Global Small Molecule Prefilled
Syringes Market Share (), by Material Type 2017
and 2025
5
  • Increasing adoption of self-injection devices is
    expected to foster growth of the small molecule
    prefilled syringes market
  • Effectiveness of drug delivery mainly depends on
    route of administration. Parenteral are highly
    preferred and commonly used route of drug
    administration. The recent past has witnessed
    significant growth in advanced drug delivery
    devices, due to development and easy availability
    of parenteral drugs. Main benefits of prefilled
    syringes over conventional drug delivery systems
    is improved product safety, self-administration,
    accurate dosing, and low chances of drug
    contamination. Self-injection advantage of
    prefilled syringes is a major factor for
    increasing adoption of these, thus aiding in
    growth of the prefilled syringe market globally.
    Apart from these aforementioned benefits,
    dual-chamber prefilled syringe may be useful with
    reconstituted drugs, which would help in avoiding
    wastage of drugs and overdose. Major
    pharmaceutical companies are focusing on
    advancing the use of self-administration devices
    globally. In 2015, SCHOTT launched a prefillable
    syringe designSCHOTT TopPac. These SD polymer
    prefillable syringes minimize the risk between
    sensitive drugs and packaging container.

6
Market Restraints
  • However, factors such as complex manufacturing
    process, high costs, and requirement of high
    quality of these products (responsible for high
    costs) are expected to hinder growth of the
    market over the forecast period.

7
Key Players
  • Some major players operating in the small
    molecule prefilled syringes market include
    Pfizer, Inc., Sanofi S.A., Mylan N.V., Teva
    Pharmaceutical Industries Ltd., Becton, Dickinson
    and Company, and Fresenius Kabi AG.

8
  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Reference https//www.coherentmarketinsights.com
    /market-insight/small-molecule-prefilled-syringes-
    market-1629

9
About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions.
  • What we provide
  • Customized Market Research Services
  • Industry Analysis Services
  • Business Consulting Services
  • Market Intelligence Services
  • Long term Engagement Model
  • Country Specific Analysis

10
Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt.Ltd.
  • Address 1001 4th Ave, 3200 Seattle, WA 98154,
    U.S.
  • Phone 1-206-701-6702
  • Email sales_at_coherentmarketinsights.com

11
  • Thank You!
  • Kindly follow CMI Social Media Profiles
    for the latest company updates
  • Facebook
  • Linkedin
  • Twitter
  • https//www.coherentmarketinsights.com/
About PowerShow.com